IL6 and demyelinating disease: Although decompressive craniectomy and immunotherapy with steroids were effective in the present case, it may be important to evaluate IL‐6 levels in the CSF, and administration of IL‐6 receptor inhibitors may be one treatment option for the clinical management of fulminant demyelinating disease, considering that mortality and serious disability may accompany the disease.